In this #DoctorPodcasts Episode 149, we sit down with physician, Professor Carel le Roux, a global authority in metabolic medicine, #obesity and #diabetes to discuss the revolutionary shift in anti-obesity medications. We break down the differences between current leading GLP-1 drugs like #Ozempic (semaglutide) and #Mounjaro (tirzepatide), and look ahead to next-generation treatments. Dr. le Roux shares exclusive insights into the Phase 3 data for #Survodutide (Boehringer Ingelheim’s dual GLP-1/glucagon agonist), including its groundbreaking impact on visceral fat and #FattyLiverDisease (MASLD/MASH) via the SYNCHRONIZE trials. We also explore Eli Lilly’s upcoming triple agonist, Retatrutide. If you want to understand the future of weight loss, #MetabolicHealth, and how these drugs target the brain-gut axis, this deep dive is for you.0:00 - Introduction & Guest Overview0:34 - Episode Welcome: Dr. Robert Cykiert0:48 - Entering Dublin: The GLP-1 Breakthrough2:27 - Long-Term Health Hazards of Obesity & Diabetes3:24 - Why Obesity is a Disease of the Brain, Not Willpower4:57 - Ozempic (Semaglutide) vs. Mounjaro (Tirzepatide)6:16 - The Fatty Liver Disease (MASLD/MASH) Epidemic7:50 - The Truth About Visceral vs. Ectopic Fat10:04 - Survodutide Explained: The New Dual Agonist12:45 - Managing Side Effects & Titration Schedules15:37 - Boehringer Ingelheim & the Future of Obesity Medicine16:48 - Retatrutide: Eli Lilly’s New Triple Agonist18:26 - A 30-Second Guide for Doctors & Patients20:11 - Closing Thoughts & Patient Transformations

Cataract surgery just entered a golden age with the recent historic FDA approval of the Johnson & Johnson (J&J) TECNIS PureSee IOL (intraocular lens). In Episode 146 of the @DoctorPodcasts Show, host Dr. Robert Cykiert speaks with world-renowned cataract surgeon, Dr. Eric Donnenfeld, and J&J Vision Senior Medical Director and ophthalmologist, Dr. Brian Schwam, to break down this major milestone. If you or a loved one suffer from blurry vision, halos and glare due to cataracts, standard monofocal IOL lenses often lock you into wearing reading glasses all the time. The J&J Tecnis PureSee represents a massive premium IOL leap forward—using a purely refractive design rather than older diffractive rings. This allows patients to maintain maximum contrast sensitivity and crisp vision across all distances - distance, intermediate and near - without losing light intensity, contrast and brightness. Discover why 97% of PureSee patients recommend this treatment and whether you are a prime candidate for this IOL lens. Subscribe to The DoctorPodcasts Show for frequent medical expert insights!

#Cataract

#Tecnis

#EyeHealth

#Ophthalmology

#DoctorPodcasts

#PureSee

Important Safety Information: https://jjvision.com/en-us/safety-information/?tab=4

0:00 - Introducing the J&J Tecnis PureSee Lens Breakthrough 0:21 - Welcome to The Doctor Podcast Show Ep. 146

1:03 - Meet Expert Pioneers Dr. Donnenfeld & Dr. Schwam 3:16 - What is a Cataract and Why Do We Get Them?

4:23 - Main Symptoms: Blurry Vision, Glare, and Halos

5:21 - Standard Monofocal Lenses vs. Premium Options

8:52 - How Multifocal and Extended Depth of Focus (EDOF) Work 10:09 - The Biggest Trade-offs of Older Eye Implants

11:55 - Rigorous FDA Clinical Trials Criteria Explained

15:21 - Refractive vs. Diffractive Design: Stopping Light Splitting 17:41 - Over 500,000 Safe International Implantations

22:26 - Real-World Evidence & High Patient Satisfaction

23:24 - Who is a Good Candidate for the PureSee Lens?

25:36 - 25 Years of Innovation at J&J Vision 27:32 - Final Expert Advice: Choosing the Right Ophthalmologist 29:10 - The Future of Eye Care: AI and Robotic Cataract Surgery

DoctorPodcasts video podcast EPISODE 148:Watch David L. Battinelli M.D, , Dean of the Zucker School of Medicine and Physician-in-Chief of Northwell Health in Long Island, NY, co-author of a new book, Revolutionizing Medical Education: A Proven Blueprint to Transform Curricula and Prepare Future-Ready Physicians, discuss how to change traditional medical school curricula to prepare physicians for modern medicine in the AI age. Book information at: https://www.wiley.com/en-us/Revolutionizing+Medical+Education%3A+A+Proven+Blueprint+to+Transform+Curricula+and+Prepare+Future-Ready+Physicians-p-9781394416042 Dr. Battinelli information at: https://faculty.medicine.hofstra.edu/1484-david-battinelli#DoctroPodcasts is the leading physician-hosted video podcast that informs, inspires and builds trust in healthcare and medicine. Watch all 148 episodes of the DoctorPodcasts || Cykiert Files video podcast interview show with physicians, scientists, healthcare specialists, entrepreneurs and other experts. Please SUBSCRIBE & FOLLOW @DoctorPodcasts. Please LIKE, REPOST/QUOTE and SHARE the episodes https://www.doctorpodcasts.com/index-of-doctorpodcasts-episodes/.Send questions, comments, suggestions, reviews and messages to @DoctorPodcasts. Thank you. Robert Cykiert, M.D.#AIinMedicine

#MedicalEducation

#FutureOfMedicine

#MedEd

#HealthcareAI

#DoctorPodcast

#MedicalSchool

#RevolutionizingMedEd

#HealthTech

#AIMedicalEducation

#PhysicianLeadership

#DigitalHealth

#MedStudentLife

#PodcastForDoctors

#AIinHealthcare

#DoctorPodcasts

#FutureDoctors

#MedicalInnovation

#CykiertFiles

#healthcareleadership #hofstra #northwell

#battinelli